rel="nofollow" href="#ulink_970e378b-e66b-53cc-99aa-bf41ac942464">47Nesper PL, Lutty GA, Fawzi AA: Residual choroidal vessels in atrophy can masquerade as choroidal neovascularization on optical coherence tomography angiography. Retina 2018;38:1289–1300.
48Missotten GS, Notting IC, Schlingemann R, et al: Vascular endothelial growth factor A in eyes with uveal melanoma. Arch Ophthalmol 2006;124:1428–1434.
49Vinores SA, Küchle M, Mahlow J, et al: Blood-ocular barrier breakdown in eyes with ocular melanoma. A potential role for vascular endothelial growth factor/vascular permeability factor. Am J Pathol 1995;147:1289–1297.
50Boyd SR, Tan D, Bunce C, et al: Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window. Br J Ophthalmol 2002;86:448–452.
51Koulisis N, Kim AY, Chu Z, et al: Quantitative microvascular analysis of retinal venous occlusions by spectral domain optical coherence tomography angiography. PLoS One 2017;12:e0176404.
52Noma H, Funatsu H, Mimura T, et al: Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Ophthalmology 2009;116:87–93.
53Samara WA, Shahlaee A, Adam MK, et al: Quantification of diabetic macular ischemia using optical coherence tomography angiography and its relationship with visual acuity. Ophthalmology 2017;124:235–244.
54Lee J, Moon GB, Cho AR, Yoon YH: Optical coherence tomography angiography of DME and its association with anti-VEGF treatment response. Ophthalmology 2016;123:2368–2375.
55Goudot MM, Sikorav A, Semoun O, et al: Parafoveal oct angiography features in diabetic patients without clinical diabetic retinopathy: a qualitative and quantitative analysis. J Ophthalmol 2017;2017:8676091.
56Chen Qi, Ma Q, Wu C, et al: Macular vascular fractal dimension in the deep capillary layer as an early indicator of microvascular loss for retinopathy in type 2 diabetic patients. Invest Ophthalmol Vis Sci 2017;58:3785–3794.
57Ting DSW, Tan GSW, Agrawal R, et al: Optical coherence tomographic angiography in type 2 diabetes and diabetic retinopathy. JAMA Ophthalmol 2017;135:306–312.
58Gupta N, Mansoor S, Sharma A, et al: Diabetic retinopathy and VEGF. Open Ophthalmol J 2013;7:4–10.
59Skalet AH, Liu L, Binder C, et al: Quantitative OCT angiography evaluation of peripapillary retinal circulation after plaque brachytherapy. Ophthalmol Retina 2018;2:244–250.
60Sioufi K, Say EAT, Ferenczy S, Shields CL: Parafoveal microvascular features on optical coherence tomography angiography in eyes with circumscribed choroidal hemangioma. Retina 2018;38:1091–1099.
61Chetrit M, Bonnin S, Mane V, et al: Acute pseudophakic cystoid macular edema imaged by optical coherence tomography angiography. Retina 2018;38:2073–2080.
62Moein HR, Novais EA, Rebhun CB, et al: Optical coherence tomography angiography to detect macular capillary ischemia in patients with inner retinal changes after resolved diabetic macular edema. Retina 2018;38:2277–2284.
63Jampol LM, Moy CS, Murray TG, et al: The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002;109:2197–2206.
64Shields CL, Naseripour M, Cater J, et al: Plaque radiotherapy for large posterior uveal melanoma (≥8-mm thick) in 354 consecutive patients. Ophthalmology 2002;109:1838–1849.
65Gunduz K, Shields CL, Shields JA, et al: Radiation complications and tumor control after plaque radiotherapy of choroidal melanoma with macular involvement. Am J Ophthalmol 1999;127:579–589.
66Gunduz K, Shields CL, Shields JA, et al: Radiation retinopathy following plaque radiotherapy for posterior uveal melanoma. Arch Ophthalmol 1999;117:609–614.
67Shah SU, Shields CL, Bianciotto CG, et al: Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma. Ophthalmology 2014;121:269–275.
68Brown GC, Shields JA, Sanborn G, et al: Radiation retinopathy. Ophthalmology 1982;89:1494–1501.
69Horgan N, Shields CL, Mashayekhi A, Shields JA: Classification and treatment of radiation maculopathy. Curr Opin Ophthalmol 2010;21:233–238.
70Kinyoun JL, Lawrence BS, Barlow WE: Proliferative radiation retinopathy. Arch Ophthalmol 1996;114:1097–1100.
71Boldt HC, Melia BM, Liu JC, Reynolds SM; Collaborative Ocular Melanoma Study Group: I-125 brachytherapy for choroidal melanoma: photographic and angiographic abnormalities. The Collaborative Ocular Melanoma Study: COMS Report No. 30. Ophthalmology 2009;116:106–115.
72Bianciotto C, Shields CL, Pirondini C, et al: Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma. Ophthalmology 2010;117:1005–1012.
73Diabetic Retinopathy Clinical Research Network: Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006;124:1701–1707.
74Diabetic Retinopathy Clinical Research Network: Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007;114:1520–1525.
75Veverka KK, AbouChehade JE, Iezzi R Jr, Pulido JS: Noninvasive grading of radiation retinopathy: the use of optical coherence tomography angiography. Retina 2015;35:2400–2410.
76Finger PT, Kurli M: Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy. Br J Ophthalmol 2005;89:144–149.
77Sellam A, Coscas F, Rouic LLL, et al: Optical coherence tomography angiography of macular features after proton beam radiotherapy for small choroidal melanoma. Am J Ophthalmol 2017;181:12–19.
78Ishibazawa